Lung Neoplasm Malignant Clinical Trial
Official title:
The Improvement of the Quality of Life and Exercise Capacity Through Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy
It is important for clinicians to maintain and support for exercise capacity and quality of life of lung cancer patients after radiation therapy, because radiation therapy also affect the lung function and general conditions of patients. The effect and safety of pulmonary rehabilitation is well-proven in various diseases. Because there is no standard treatment, the investigators will perform this study to clearly prove the effect of pulmonary rehabilitation in lung cancer patients receiving radiation therapy.
Roles of the radiation therapy in lung cancer are as followings; 1) to treat the lung caner stage 1 ~2 patients, who are inadequate for operation due to declined lung function, 2) to treat the locally advanced and inoperable stage 3 patients with concurrent chemotherapy, and 3) to palliatively treat the stage 4 patient. However, it is also possible that radiation therapy worsens the general weakness and lung function, although the degree of deterioration was generally less than lung resection. Therefore, it is crucial for clinicians to maintain and support for exercise capacity and quality of life of lung cancer patients after radiation therapy. The effect and safety of pulmonary rehabilitation is well-proven in various diseases. Investigators presented a retrospective study about the effect of pulmonary rehabilitation in patients receiving radiation therapy, which showed less decreased lung function, less radiation related pneumonitis, and decreased mortality. Investigators will perform this study to clearly prove the effect of pulmonary rehabilitation in lung cancer patients receiving radiation therapy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05890872 -
Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer
|
N/A | |
| Recruiting |
NCT05974475 -
MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
|
||
| Recruiting |
NCT06079970 -
Confocal Laser Endomicroscopy VERification
|
N/A | |
| Recruiting |
NCT04973293 -
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
|
N/A | |
| Recruiting |
NCT04778826 -
Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy
|
N/A | |
| Suspended |
NCT04036721 -
Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis
|
Phase 4 | |
| Completed |
NCT03352245 -
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
|
N/A | |
| Completed |
NCT03834116 -
Resistance Inspiratory Muscle Training for Patients With Thoracic Malignancies
|
N/A | |
| Completed |
NCT03824977 -
Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery
|
||
| Terminated |
NCT02985203 -
Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT05241873 -
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
|
Phase 1/Phase 2 | |
| Completed |
NCT05404022 -
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years
|
N/A | |
| Recruiting |
NCT03525782 -
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
|
Phase 1/Phase 2 | |
| Completed |
NCT04059887 -
Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]
|
Phase 4 | |
| Terminated |
NCT05013554 -
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
|
Phase 1 |